1.29
price up icon6.61%   0.08
after-market Handel nachbörslich: 1.28 -0.01 -0.78%
loading
Schlusskurs vom Vortag:
$1.21
Offen:
$1.2
24-Stunden-Volumen:
101.56K
Relative Volume:
0.09
Marktkapitalisierung:
$14.60M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.70M
KGV:
-1.1727
EPS:
-1.1
Netto-Cashflow:
$-8.57M
1W Leistung:
+2.38%
1M Leistung:
-18.35%
6M Leistung:
-17.83%
1J Leistung:
-64.66%
1-Tages-Spanne:
Value
$1.20
$1.31
1-Wochen-Bereich:
Value
$1.11
$1.31
52-Wochen-Spanne:
Value
$0.95
$5.95

Marker Therapeutics Inc Stock (MRKR) Company Profile

Name
Firmenname
Marker Therapeutics Inc
Name
Telefon
(713) 400-6400
Name
Adresse
2450 HOLCOMBE BLVD, HOUSTON, TX
Name
Mitarbeiter
5
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
MRKR's Discussions on Twitter

Vergleichen Sie MRKR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MRKR
Marker Therapeutics Inc
1.29 13.69M 0 -9.70M -8.57M -1.10
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Marker Therapeutics Inc Stock (MRKR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-05 Eingeleitet Canaccord Genuity Buy
2021-03-25 Eingeleitet Piper Sandler Overweight
2021-03-19 Eingeleitet Cantor Fitzgerald Overweight
2020-05-12 Herabstufung Piper Sandler Overweight → Neutral
2019-05-30 Eingeleitet ROTH Capital Buy
2019-03-01 Eingeleitet Janney Buy
2018-12-03 Hochstufung Piper Jaffray Neutral → Overweight
Alle ansehen

Marker Therapeutics Inc Aktie (MRKR) Neueste Nachrichten

pulisher
Aug 20, 2025

Exit strategy if you’re trapped in Marker Therapeutics Inc.Trade Performance Summary & Growth Focused Stock Pick Reports - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Published on: 2025-08-21 02:07:42 - newsyoung.net

Aug 20, 2025
pulisher
Aug 20, 2025

Is it time to cut losses on Marker Therapeutics Inc.Quarterly Trade Summary & Weekly Watchlist for Consistent Profits - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Can you recover from losses in Marker Therapeutics Inc.Earnings Overview Summary & Community Verified Swing Trade Signals - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Can machine learning forecast Marker Therapeutics Inc. recovery2025 Volatility Report & Short-Term Trading Alerts - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Is Marker Therapeutics Inc. forming a bottoming baseWeekly Trade Analysis & Safe Swing Trade Setups - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Can trapped investors hope for a rebound in Marker Therapeutics Inc.Trade Ideas & Weekly Top Gainers Trade List - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Momentum divergence signals in Marker Therapeutics Inc. chartJuly 2025 News Drivers & High Conviction Buy Zone Picks - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Watch for Bullish Crossover in Marker Therapeutics Inc.July 2025 Weekly Recap & Community Supported Trade Ideas - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Short interest data insights for Marker Therapeutics Inc.2025 Macro Impact & Low Risk Entry Point Tips - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Marker Therapeutics Inc. Rebound Backed by Sentiment ShiftTrade Ideas & Verified Momentum Stock Watchlist - classian.co.kr

Aug 19, 2025
pulisher
Aug 19, 2025

Applying chart zones and confluence areas to Marker Therapeutics Inc.July 2025 Summary & Daily Stock Trend Reports - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

What makes Marker Therapeutics Inc. stock attractive to long term investorsJuly 2025 Update & Short-Term Swing Trade Alerts - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Marker Therapeutics Posts Q2 2025 Earnings Loss Amid Weak Market Reaction - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

Is Marker Therapeutics Inc. meeting your algorithmic filter criteriaTrade Risk Assessment & Expert Approved Momentum Trade Ideas - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Will Marker Therapeutics Inc. continue its uptrendJuly 2025 News Drivers & Stock Market Timing Techniques - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Using Bollinger Bands to evaluate Marker Therapeutics Inc.2025 Market Outlook & Low Risk Profit Maximizing Plans - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Using economic indicators to assess Marker Therapeutics Inc. potentialWeekly Trade Recap & Safe Capital Preservation Plans - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Marker Therapeutics Posts Q2 2025 Earnings Loss Amid High Costs and Weak Market Reaction - AInvest

Aug 17, 2025
pulisher
Aug 17, 2025

Is Marker Therapeutics Inc. a Top Dividend Stock to Watch in 2025Quarterly Investment Review & Fast Moving Trade Plans - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Is Marker Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis InsideWeekly Gains Report & AI Driven Price Forecasts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Will Marker Therapeutics Inc. see short term momentumJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Price action breakdown for Marker Therapeutics Inc.Insider Selling & Weekly Return Optimization Plans - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

What MACD signals say about Marker Therapeutics Inc.Earnings Growth Summary & Safe Capital Growth Plans - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Wall Street Zen Upgrades Marker Therapeutics (NASDAQ:MRKR) to “Sell” - Defense World

Aug 16, 2025
pulisher
Aug 16, 2025

Can Marker Therapeutics Inc. hit a new high this monthInsider Buying & Safe Capital Investment Plans - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Using Ichimoku Cloud for Marker Therapeutics Inc. technicalsJuly 2025 Selloffs & Free High Return Stock Watch Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Published on: 2025-08-15 15:19:17 - metal.it

Aug 15, 2025
pulisher
Aug 15, 2025

Marker Therapeutics Reports Increased R&D Expenses Amid Revenue Decline - TipRanks

Aug 15, 2025
pulisher
Aug 14, 2025

Marker Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 14, 2025
pulisher
Aug 14, 2025

Marker Therapeutics, Inc. SEC 10-Q Report - TradingView

Aug 14, 2025
pulisher
Aug 13, 2025

Promising Developments and Market Potential Drive Buy Rating for Marker Therapeutics - TipRanks

Aug 13, 2025

Finanzdaten der Marker Therapeutics Inc-Aktie (MRKR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Marker Therapeutics Inc-Aktie (MRKR) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
New Enterprise Associates 16,
10% Owner
Dec 23 '24
Buy
3.20
554,250
1,773,600
1,625,678
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Kapitalisierung:     |  Volumen (24h):